PV Cancer Research Results
PV, Prostate Volume: Click to Expand ⟱
| Source: |
| Type: |
| Prostate Volume
|
Scientific Papers found: Click to Expand⟱
*Dose↝, PEMF (5 min, twice a day for 3 weeks) was performed on 20 dogs affected by BPH. (Magcell® Vetri, Physiomed Elektromedizin AG, Schnaittach, Germany
*toxicity↓, The efficacy of PEMF on BPH in dogs, with no side effects, suggests the suitability of this treatment in humans and supports the hypothesis that impairment of blood supply to the lower urinary tract may be a causative factor in the development of BPH
*BloodF↑,
*Dose↝, A frequency of 4–12 Hz and intensity of 1000 Gauss was used. The magnetic field maximum strength was 200 mT. ( ±105 mT ) pulse rate of 12.5 ms
*PV↓, progressive reduction of prostatic volume was recorded from T0 to T3. Prostate volume decreased an average of 57% over the course of the study,
*Inflam↓, The anti-inflammatory function of electromagnetic-fields [34] should also be considered.
*PV↓, PEMF) to treat men suffering from benign prostatic hyperplasia (BPH). After one month of
treatment, prostate volume and symptoms significantly decreased.
*Inflam↓, The electromagnetic field is produced by a device that reduces inflammation by promoting growth of new blood vessels, dilation of blood vessels, and tissue remodeling.
*BloodF↑, PEMF was able to significantly reduce prostate volume after just 28 days of therapy,
resulting in a median decrease of 5.4%
*Dose↝, handheld PEMF device (Magcell® Microcirc, Physiomed Elektromedizin) for five minutes twice daily for 28 consecutive days.
PV↓, Recently, Leoci et al. [22] reported a significant reduction of prostatic volume (57%) without any changes on semen quality, libido, or testosterone levels of 20 dogs treated twice daily for 3 weeks
*Inflam↓, Pulsed electromagnetic field therapy (PEMF) (1‐50 Hz) is effective in reducing tissue inflammation.
*Dose↝, Magcell® Microcirc, Physiomed Elektromedizin AG, Scnaittach, Germany, Figure 2), with a frequency of 4‐12 Hz and an intensity of 1000 Gauss
*other?, The overall effect is a reduction in tissue hypoxia and therefore a reduction in prostatic growth
*PV↓, A reduction was observed both at V1 and at V2 in PV: PVV0 44.5 mL (38.0;61.6) vs PVV1 42.1 mL (33.7;61.5, P = .039) vs PVV2 41.7mL (32.7;62.8, P = .045).
*eff↑, PV reduction in patients without metabolic syndrome (ΔPVV1nMetS −4.7 mL, 95%CI −7.3;‐2.0) was greater than in affected patients
*Ca+2↝, PEMF seems to increase intracellular calcium (Ca2+) binding to calmoduline
*Dose↝, radiofrequencies generated by an ion magnetic inductor, for 30 min daily, 5 consecutive days per week.
*PV↓, here was a statistically significant decrease before and after treatment of IPSS (P < 0.02), U/S prostate volume (P < 0.05), and urine residue (P < 0.05), as well as of mean urine flow rate (P < 0.05) in patients of the electromagnetic group,
*UFR↑,
*UR↓,
*QoL↑, significant improvement in clinical symptoms in patients of the electromagnetic group. Follow-up of the patients of this group for one year revealed that results obtained by EMFs treatment are still remaining.
*Dose↝, The Ion Magnetic Inductor, (PAPIMIÒ device, model 600 Pulse Dynamics Athens, Greece) was used for the electromagnetic treatment of the patients.
*Dose↝, 35–80 J/pulse for energy, 1 x 10-6 s for wave duration, 35–80 x 10-6 W for wave power, amplitude of the order of 12.5 mT, rise time 0.1 us, fall time 10 us, and repetitive frequency of 3–8 Hz.
*Dose↝, antenna loop of this device (30 x 15 cm, one winding with two turns), which produces a short-duration bipolar PEMF, was horizontally centered over the pubic area and under the perineum of the patients at a maximum distance of 5 cm from the skin.
*Dose↝, Patients were exposed for 15 min in each of the areas (total 30 min) to the PAPIMI device pulses at a frequency of 750 kHz and at a rate of 4 pulses per second (pps).
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
PV↓, 1,
Total Targets: 1
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
PV↓, 4, UFR↑, 1, UR↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other?, 1,
Migration(tgid=13) ⓘ
Ca+2↝, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 3,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 9, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
BloodF↑, 2,
Functional Outcomes(tgid=23) ⓘ
QoL↑, 1, toxicity↓, 1,
Total Targets: 11
Scientific Paper Hit Count for: PV, Prostate Volume
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1540 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page